Blarcamesine Shows Promising Results in Alzheimer’s Phase 2b/3 Trial
OnAnavex Life Sciences has announced groundbreaking results from its recent Phase 2b/3 clinical trial involving the investigational drug blarcamesine. This trial assessed the drug’s.
Read More